Alarm as 10 HIV drugs out of stock
Health & Science
By
Anyango Otieno and Graham Kajilwa
| Oct 07, 2020
There is a shortage of 10 crucial HIV/Aids drugs as a result of Covid-19 pandemic, the UN has warned.
In a latest report by UNAids, at least 10 anti-retroviral therapy (ART) medication is in short supply.
They include Tenofovir, Abacavuir, Cotrimoxazole suspension, Ritonavir tablets, Nevirapine suspension (for new born), Zidovudine solution, Zidovudine/lamivudine (AZT/3TC), Lopinavir/ Ritonavir(LPV/r) 100/25 mg, and LPV/r pellets 40/10 formulation.
A model by the World Health Organisation and the Joint United Nations Programmes on HIV and Aids (UNAids) estimated a six-month disruption of antiretroviral therapy could lead to more than 500 000 additional Aids-related deaths, including from tuberculosis, in sub-Saharan Africa in 2020–2021.
READ MORE
Equity Q1 net profit up 24pc to Sh18.3b on regional units
KCB Q1 net earnings hit Sh17.8b to join rivals in defying tough times
Centum Re begins handover of 400 apartments at Nairobi's Two Rivers
Epra makes marginal hike on pipeline tariff, piles pressure on consumers
ICPAK urges accountants to restore trust in public institutions
Alarm raised over lagging decarbonisation in construction industry
Retail investors can now own a piece of mega infrastructure projects through NSE
Why AI is gaining prominence in Africa's new investment agenda
New push to formalise garbage collection SMEs
The power of patience, psychology and strategy in debt recovery
In Kenya, persons living with HIV have already confirmed a short supply of Cotrimoxazole, which is sold as Septrin.